Feb 05, 2026

Subject: 🏥 LLMs are Dead? Insights from Nabla’s AI Executive Retreat & Healthcare Week Recap

Sender: hospitalogy@workweek.com

Summary:

– Yann LeCun, at Nabla’s retreat, argued current large language models (LLMs) are nearing a functional ceiling and that world models training on sensory data (videos, images) are the future of AI, especially for healthcare.

– World models will better understand complex systems in healthcare and enable autonomous, safe AI. Nabla is partnering with LeCun’s AMI Labs to develop these models.

– Despite AI advances, human elements in healthcare – trust, relationship, care quality – remain core.

– Topics discussed include AI readiness, job displacement concerns, Medicaid patient engagement, AI guardrails, liability, and regulatory challenges.

– Anticipated AI impact in 5-10 years spans clinical decision support, care navigation, revenue cycle, primary care, and medical education.

– Industry updates: Tenet’s $1.9B acquisition of Conifer, CommonSpirit’s portfolio transformation, mergers like Premise-Crossover Health, Kaiser Permanente’s worker strike, and regulatory developments.

– Recommended reads on health AI landscape, provider-sponsored plans, CMS policy proposals, managed care trends, and virtual care markets.

Call to Action:

– Download Weaver’s Healthcare Valuation 2025 report.

– Join upcoming Hospitalogy events and network with healthcare leaders.

Subject: Thai Healthcare Stocks Face Challenges; Medical Gas Market Growth & AI Patient Engagement Projections

Sender: healthcareasia@cmgnewsletter.com

Summary:

– Institutional investors are exiting Thai healthcare stocks due to an affordability wall and capped private hospital growth.

– Chronic diseases and aging populations fuel growth in the medical gas market across Asia-Pacific.

– AI patient engagement market is forecasted to reach $33.68 billion by 2032 with 20.9% CAGR, driven by cloud deployment cost advantages.

– India’s Bio Pharma Shakti scheme targets local drug R&D and reducing import reliance.

– Ophthalmic diseases are imposing growing strains in Asia-Pacific healthcare systems.

– Australia launched an Open Science Policy mandating open sharing of health research data and methods.

– IHH Healthcare invests in advanced radiotherapy technology that shortens treatment duration 400x.

– Pharmacy automation devices market is projected to grow steadily, reaching $9.83 billion by 2028.

Upcoming Events: Healthcare Asia Summit (Mar 25, 2026); Pharma and Medtech Awards (Mar 26, 2026).

Subject: The Trump Admin Blocked Fast-Track Review for Psilocybin Drug

Sender: newsletter@statnews.com

Summary:

– The Trump administration vetoed a fast-track priority review voucher for Compass Pathways’ psilocybin treatment, reflecting conservative drug policy influences.

– American Society of Plastic Surgeons recommends delaying gender-affirming surgeries for youth until age 19, diverging from other groups supporting earlier care, amidst political pressures.

– New Canadian study links maternal diabetes (pre-gestational and gestational) with increased epilepsy risk in offspring, especially type 2 diabetes (40% increased risk). Authors urge early neurological monitoring for exposed children.

– Academic research trends: staying near a former advisor’s research aids young scientists’ success up to a point; signaling independence remains important.

– Opioid treatment access remains poor in suburbs due to long travel times to methadone clinics, further complicating recovery efforts.

– First opinion piece on the life-ruining side effects of a dopamine agonist drug used to treat restless leg syndrome.

Subject: 🥼 Foreign Doc Dilemmas & Trump Admin’s Visa and Healthcare Policy Updates

Sender: vitals@axios.com

Summary:

– Rural US healthcare heavily depends on immigrant doctors disproportionately; new $100K H-1B visa fee threatens to exacerbate physician shortages in rural and underserved areas.

– Congress delayed Medicare cuts to clinical lab tests for another year after sustained industry pushback.

– American Society of Plastic Surgeons advises delaying transition-related surgeries for youth until 19 citing insufficient evidence and potential harms; a position aligned with Trump administration’s stricter gender care policies.

– Public payers (Medicare, Medicaid, federal/state employees) cover over half of outpatient prescription drug spending, with rapid growth fueled by demand for GLP-1 weight loss drugs.

– Other notes: Florida’s drug import program stalls, FDA conflict of interest probe ongoing, Colorado considers ibogaine for medical use.

Subject: More Than One-Third of Cancer Cases Are Preventable

Sender: briefing@nature.com

Summary:

– Nearly 40% of new worldwide cancer cases in 2022 linked to modifiable risk factors: smoking (top contributor), infections, alcohol use.

– Cuts to global health development funding could cause 9.4 million additional deaths over next 4 years, especially in children under 5.

– NIH is easing bureaucratic regulations on non-clinical human research to reduce red tape while balancing transparency goals.

– Aletheia-Probe, a “truth” tool, helps scientists identify legitimate versus predatory journals and conferences to avoid scams.

– Quantum computing advances signal a “new era,” with drastically reduced error rates potentially bringing real-world applications sooner.

– UK university campus closures threaten local economies and student outcomes.

– The history of ice skates highlights evolution from bone skates to metal blades improving maneuverability.

Subject: 🎤 More Speakers Just Added to Breakthrough Easts

Sender: marketing@statnews.com

Summary:

– STAT Breakthrough East conference in NYC on March 19, 2026 adds new speakers including top executives from Bristol Myers Squibb, Eli Lilly, AstraZeneca Rare Disease, Biogen, Alnylam, and expert science communicators.

– Sessions focus on translating research breakthroughs into real-world impact across health and medicine fields.

– Registration open for in-person and online attendance; limited passes available.

– STAT Breakthrough Summit West scheduled for May 2026 with early access registration.

Call to Action: Secure your pass now for insights from industry leaders shaping future therapies and technologies.

Stay Well!